Data / Form D filings / BioKier, Inc.
BioKier, Inc.: Form D filings
BioKier, Inc., a biotechnology company in Chapel Hill, NC, filed 12 Form D notices with the SEC between 2009 and 2014. The latest, on October 8, 2014, reports $230,000 sold of a $1 million offering to 7 investors.
Find out what BioKier, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 105 GREEN WILLOW COURT, Chapel Hill, NC, 27514
- Phone
- (919) 323-6497
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1469459
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 8, 2014 | Amendment | $1,000,000 | $230,000 | $770,000 | 7 | May 23, 2014 | sec.gov |
| Aug 4, 2014 | New notice | $1,000,000 | $150,000 | $850,000 | 3 | May 23, 2014 | sec.gov |
| Jul 19, 2013 | New notice | $1,710,000 | $645,000 | $1,065,000 | 1 | Jul 12, 2013 | sec.gov |
| Jun 7, 2013 | New notice | $400,000 | $40,000 | $360,000 | 1 | May 14, 2013 | sec.gov |
| Feb 19, 2013 | Amendment | $400,000 | $340,000 | $60,000 | 17 | Aug 31, 2011 | sec.gov |
| Sep 14, 2012 | Amendment | $400,000 | $225,000 | $175,000 | 12 | Aug 31, 2011 | sec.gov |
| Apr 18, 2012 | Amendment | $400,000 | $155,000 | $245,000 | 7 | Aug 31, 2011 | sec.gov |
| Mar 15, 2012 | Amendment | $400,000 | $105,000 | $295,000 | 6 | Aug 31, 2011 | sec.gov |
| Sep 26, 2011 | New notice | $400,000 | $50,000 | $350,000 | 1 | Aug 31, 2011 | sec.gov |
| Oct 14, 2009 | Amendment | $250,000 | $249,999 | $1 | 1 | Jul 29, 2009 | sec.gov |
| Oct 9, 2009 | Amendment | $250,000 | $199,999 | $50,001 | 1 | Jul 29, 2009 | sec.gov |
| Aug 7, 2009 | New notice | $250,000 | $99,999 | $150,001 | 1 | Jul 29, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| James R Farrelly | Director | |
| Jerzy R Szewczyk | Executive Officer, Director | |
| Roger Nolan | Executive Officer, Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Oct 6, 2014 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what BioKier, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.